Stenocare AS
Stenocare A/S cultivates, produces, imports, distributes, and sells prescription-based medical cannabis products to patients in Denmark and internationally. It offers medical cannabis oil products, including THC, THC/CBD, and CBD oil products. The company was incorporated in 2017 and is based in Randers, Denmark.
Market Cap & Net Worth: Stenocare AS (STENO)
Stenocare AS (CO:STENO) has a market capitalization of $5.26 Million (Dkr38.20 Million) as of March 19, 2026. Listed on the CO stock exchange, this Denmark-based company holds position #32046 globally and #101 in its home market, demonstrating a -22.48% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Stenocare AS's stock price Dkr1.00 by its total outstanding shares 38195978 (38.20 Million).
Stenocare AS Market Cap History: 2020 to 2026
Stenocare AS's market capitalization history from 2020 to 2026. Data shows change from $103.25 Million to $5.26 Million (-45.77% CAGR).
Stenocare AS Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Stenocare AS's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
1.11x
Stenocare AS's market cap is 1.11 times its annual revenue
1.02x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2020 | $103.25 Million | $198.45K | -$11.79 Million | 520.27x | N/A |
| 2021 | $54.36 Million | $1.57 Million | -$12.73 Million | 34.51x | N/A |
| 2022 | $48.31 Million | $4.49 Million | -$16.30 Million | 10.76x | N/A |
| 2023 | $13.35 Million | $3.76 Million | -$17.57 Million | 3.55x | N/A |
| 2024 | $6.83 Million | $2.23 Million | -$34.49 Million | 3.06x | N/A |
| 2025 | $7.78 Million | $7.02 Million | -$2.39 Million | 1.11x | N/A |
Competitor Companies of STENO by Market Capitalization
Companies near Stenocare AS in the global market cap rankings as of March 19, 2026.
Key companies related to Stenocare AS by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #410 globally with a market cap of $53.52 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #434 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #457 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #721 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #410 | Zoetis Inc | NYSE:ZTS | $53.52 Billion | $121.68 |
| #434 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.60 |
| #457 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #721 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.19 Billion | CN¥55.11 |
Stenocare AS Historical Marketcap From 2020 to 2026
Between 2020 and today, Stenocare AS's market cap moved from $103.25 Million to $ 5.26 Million, with a yearly change of -45.77%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Dkr5.26 Million | -32.43% |
| 2025 | Dkr7.78 Million | +13.85% |
| 2024 | Dkr6.83 Million | -48.82% |
| 2023 | Dkr13.35 Million | -72.36% |
| 2022 | Dkr48.31 Million | -11.12% |
| 2021 | Dkr54.36 Million | -47.35% |
| 2020 | Dkr103.25 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Stenocare AS was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $5.26 Million USD |
| MoneyControl | $5.26 Million USD |
| MarketWatch | $5.26 Million USD |
| marketcap.company | $5.26 Million USD |
| Reuters | $5.26 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.